Navigation Links
New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma
Date:3/28/2011

PINE BROOK, N.J., March 28, 2011 /PRNewswire/ -- Diopsys, Inc. has launched the new Diopsys® NOVA-DN VEP Vision Testing System to help optometrists and ophthalmologists detect optic nerve disease, including glaucoma and other neuro-visual disorders.

Glaucoma is the second leading cause of blindness in the world, reports the World Health Organization. According to Prevent Blindness America, glaucoma is often called the "sneak thief of sight" because half of all patients who have it do not know it.  Many optic nerve disorders, such as glaucoma and ischemic optic neuropathy, are asymptomatic since central vision may not be affected until later stages of the disease. Also, diagnosis and management of optic nerve disorders are often based on structural or visual field tests which are limited in their ability to detect disease early.  

The Diopsys® NOVA-DN allows clinicians to objectively assess optic nerve disease earlier than traditional vision tests because it uses Visual Evoked Potential (VEP) technology and proprietary software to evaluate the entire vision system from the eye to the visual cortex. "VEP is an objective, functional test that can help discriminate between healthy and glaucomatous eyes," says Alberto Gonzalez Garcia, M.D., neuro-ophthalmologist and Research Director at Diopsys, Inc. Optometrists and ophthalmologists may use VEP in addition to traditional testing methods to enhance diagnosis and treatment.

The Diopsys® NOVA-DN records the electrical response of a patient's entire vision system and provides easy-to-read reports that give the doctor a simple way to evaluate optic nerve function.  Physicians are able to compare tests over time to track disease progression.

Dr. Fran Bucciero of Family Vision Care in Springfield, NJ, one of the first eye care professionals to have the device in his office says, "I've been using the Diopsys® NOVA-DN in my practice to help me diagnose glaucoma patients, and to track their disease progression. Because of the straightforward reports, I am able to show my patients how well their treatment is working which helps enormously with treatment compliance."  

Diopsys, Inc. (http://www.diopsys.com) is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care.  The company specializes in the development and marketing of patient-friendly, non-invasive diagnostic vision testing equipment.  Diopsys has developed and markets the patented Enfant® Pediatric Vision Testing System, a device used by pediatricians to test for visual deficits, including amblyopia, in children as young as six months of age. Diopsys also developed and markets the Diopsys® NOVA-DT (Diagnostic & Tracking), Diopsys® NOVA-TR (Transient Response) and Diopsys® NOVA-DN (Diseases of the Optic Nerve)  Vision Testing Systems utilized by ophthalmologists and optometrists for the detection, diagnosis and treatment of vision disorders.


'/>"/>
SOURCE Diopsys, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In a Phase 2 Study PF-04523655 (RTP801I-14) Showed Improved Vision Over Standard of Care in Patients with Diabetic Macular Edema at 12 Months
2. CooperVision Introduces New Corporate Brand Identity
3. New Ad Campaign: Secret Provision Raises Taxes on Prescription Drug Benefits, Creates Conflict of Interest
4. Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCares Global Consumer Care Division
5. TLC Vision Announces TLC Laser Eye Center San Diego
6. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
7. New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92%
8. Sevocity, a Division of Conceptual MindWorks, Incs Sevocity Receives ONC-ATCB 2011/2012 Certification
9. HealthWarehouse.com Acquires Online Division of Hocks Pharmacy
10. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
11. Elka Nir Joins VisionCare Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... June 9, 2017 AirXpanders, Inc. (ASX: AXP) ... the design, manufacture, sale and distribution of the AeroForm® ... progress of its commercial roll-out in the ... more than one hundred (100) medical institutions and health ... offers a needle-free alternative for women who choose reconstructive ...
(Date:6/8/2017)... June 8, 2017  Less than a month ago, ... than 200,000 companies, including hospital networks, in over 150 ... one of the largest online extortion attempts ever recorded. ... market, it is imperative that providers understand where the ... from this — and many other very real cyber ...
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
Breaking Medicine Technology:
(Date:6/22/2017)... ... ... A June 12 article in The Star offers the advice ... oral hygiene by an aged parent who had recently suffered a series of minor ... steps, including scheduling a dentist visit. Northridge Dental Works, a Los Angeles Area dental ...
(Date:6/20/2017)... ... June 20, 2017 , ... United Benefit Advisors (UBA), the ... Awards (pronounced you-bee) for 2017. The award honors Partner Firms, Principals, agency ... UBA, the clients they serve, and the benefits insurance industry as a whole. ...
(Date:6/20/2017)... ... , ... Fresenius Vascular Care, a national network of outpatient vascular care and ... wide range of vascular conditions, has today announced its new name, Azura Vascular Care, ... more than 40 local brands, a phased rollout of the new brand across all ...
(Date:6/20/2017)... ... June 20, 2017 , ... AMC Health , ... and success in the clinical trials market. Similar to its approach in demonstrating positive ... the clinical trials marketplace by proving the value of eVisits to support virtual studies. ...
(Date:6/20/2017)... ... 20, 2017 , ... As a leading dental practice, Wall Centre Dental supports ... disease. Those with bleeding gums in Vancouver, BC, may be developing gingivitis, the first ... heart disease, stroke and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer ...
Breaking Medicine News(10 mins):